United Therapeutics Corporation (NASDAQ:UTHR) Q2 2023 Earnings Conference Call August 2, 2023 9:00 AM ET

Company Participants

Dewey Steadman - Head-Investor Relations

Martine Rothblatt - Chairperson & Chief Executive Officer

Michael Benkowitz - President & Chief Operating Officer

James Edgemond - Chief Financial Officer & Treasurer

Leigh Peterson - Senior Vice President of Product Development

Conference Call Participants

Ash Verma - UBS

Eun Yang - Jefferies

Hartaj Singh - Oppenheimer

Terence Flynn - Morgan Stanley

Joseph Thome - TD Cowen

Andreas Argyrides - Wedbush

Operator

Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator today. [Operator Instructions] Please note, this call is being recorded.

I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.

Dewey Steadman

Thanks, Danielle, and good morning. It's my pleasure to welcome you to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast. Accompanying me on today's webcast are Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer; Michael Benkowitz, our President and Chief Operating Officer; James Edgemond, our Chief Financial Officer and Treasurer; Pat Poisson, our Executive Vice President of Technical Operations; and Dr. Leigh Peterson, our Senior Vice President of Product Development.

Please note that, remarks today will include forward-looking statements, representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including Forms 10-K and 10-Q contain additional information on these risks and uncertainties, and we assume no obligation to update these forward-looking statements.

Today's remarks also may discuss the progress and results of clinical trials or other developments, with respect to our products. These remarks are intended solely to educate investors and are not intended to serve as the basis for medical decision-making, or to suggest that any products are safe and effective during any unapproved or investigational uses.

Remember full prescribing information for our products are available on our website. Note that, Pat Poisson and I will be participating in one-on-one meetings at the 2023 Wedbush PacGrow Healthcare Conference on August 8. Then Michael Benkowitz, James Edgemond and I will participate in a fireside chat and one-on-one meetings at the Morgan Stanley 21st Annual Global Healthcare Conference on September 11. In addition, we will present data at the European Society of Cardiology in Amsterdam in August, the European Respiratory Society in Milan in September, and at the CHEST Annual Meeting in Hawaii in October.